RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model

Title
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model
Authors
Keywords
-
Journal
PROSTATE
Volume 68, Issue 8, Pages 820-829
Publisher
Wiley
Online
2008-03-07
DOI
10.1002/pros.20744

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started